Posted by Michael Wonder on 19 Dec 2020
FDA takes additional action in fight against COVID-19 by issuing emergency use authorisation for second COVID-19 vaccine
18 December 2020 - Action follows thorough evaluation of available safety, effectiveness, and manufacturing quality information by FDA career scientists, input from independent experts.
Today, the U.S. FDA issued an emergency use authorisation for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The emergency use authorisation allows the Moderna COVID-19 caccine to be distributed in the U.S. for use in individuals 18 years of age and older.
